Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers.
about
Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypesAutoimmune type 1 diabetes: resolved and unresolved issuesLow frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetesImmune markers for monitoring the progression of autoimmune disease.Prevention of type 1 diabetes from laboratory to public health.Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.Maternal age and risk of type 1 diabetes in children. Flawed analysis invalidates conclusions.The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion.Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes.A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1qMeasurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratoriesPerturbations in the lipid profile of individuals with newly diagnosed type 1 diabetes mellitus: lipidomics analysis of a Diabetes Antibody Standardization Program sample subsetAssessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.Advances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologiesReclassification of diabetes etiology in a family with multiple diabetes phenotypesGrowth of rotaviruses in primary pancreatic cells.Molecular signatures differentiate immune states in type 1 diabetic familiesExtrapancreatic autoantibody profiles in type I diabetesMolecular aspects of type 1 diabetesUse of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in Type 1 diabetesTracking humoral responses using self assembling protein microarraysEvidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).Rising incidence of type 1 diabetes is associated with altered immunophenotype at diagnosisPre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes.High-throughput methods for measuring autoantibodies in systemic lupus erythematosus and other autoimmune diseases.Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions.Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigensZinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis studyIslet cell autoantibodies in African patients with Type 1 and Type 2 diabetes in Dar es Salaam Tanzania: a cross sectional study.The core cysteines, (C909) of islet antigen-2 and (C945) of islet antigen-2β, are crucial to autoantibody binding in type 1 diabetes.The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.Type 1 diabetes: pathogenesis and prevention.Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and AdolescentsAutoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice.Early-onset, coexisting autoimmunity and decreased HLA-mediated susceptibility are the characteristics of diabetes in Down syndrome.
P2860
Q24811473-471467B8-0882-4D5A-8CF5-D55B4A9B1B8BQ28363451-3060B694-D49A-40FF-9EED-13F5AC6989DCQ33492771-5A6ABF17-B533-44C8-8CD7-D7DC35D8B509Q33602114-A7EA0900-42D4-4F4F-AD97-580A59FFE244Q33654261-704E2A82-2EC9-4943-8951-1A8EDCE86E32Q33703110-05F221B6-CE8E-47BE-8765-97538C499700Q33753720-A6048258-6542-4E89-9EAF-FDC414F34413Q33805935-A8836193-1FAD-46C6-9CA1-F21642BDC650Q33853806-B62B5D36-25CC-4D7D-B6E6-5D399175584DQ33884262-8F2C099B-FFA4-4E19-82AA-84B3BCA6B5DDQ34044595-5D92359A-B483-4716-A8DE-BD83A1159B96Q34051605-2A97D188-5567-4EAB-8707-841FBE4DC162Q34056584-0C5485B8-EB6B-46B0-BCB7-5AE9051C085EQ34084456-AC12D7F1-D77D-4855-BBBC-48F21C18F786Q34157932-7CE583EE-474B-441F-B04A-5D68420B33DCQ34294841-46BC2631-6BAC-4BBC-B2FC-C4A9DAFA96AEQ34346057-EE41DFBD-5BA4-454C-ADF7-0826DCEDD8B5Q34393367-AD4FEA9F-9CC7-4C7F-AD6C-2B6305946478Q34428374-8486AE9F-FC60-4C68-BA65-8F326BB7CAD1Q35057468-02352B30-3271-4CC6-B1ED-3732C559E8CDQ35062538-26C4C76E-A24B-44D9-94B2-A900A3E8E48EQ35170395-4E30DD41-FFD4-4DE9-9124-5C488C99C99EQ35227148-A0339233-37F3-4B0C-BE84-5BA314B63FE1Q35531906-2430E1C2-5E3B-4F90-99FC-8D671D55C197Q35766972-18399FB9-71A0-4B65-BF1F-ED643675AA79Q35792511-130C9A22-DA88-4734-B043-95F148C4329AQ35907005-64A10F95-4EA5-41C5-B55A-0924C46235E1Q35934672-C936C582-43CD-4CB3-8FA8-8DE4D0C688DBQ35976364-9892D1CC-94F0-41C2-9418-475E0C6C56AFQ36033860-D6351140-AA80-4E26-964B-56DE5F69A321Q36111731-5FFAA698-586B-48E0-A085-21EE20D153B5Q36249785-F5103B75-7F61-486D-9663-43323429738BQ36285920-44E22576-E10E-4B30-BE03-EC1F6223EC58Q36477325-0D6774C5-0835-4779-ACB1-34E80BDF95A4Q36535592-F33002CB-D818-4569-98AB-E08BC44159FAQ36538943-FC9F5288-EDF6-470E-8FE5-5FAC259B4130Q36547660-C3F1B15F-156A-4898-B29A-8C5A8335640DQ36681606-5F0C3C26-4393-495C-B070-F999AA418F80Q36737669-D8CD0201-133D-454B-8CE0-E71F3CCCF260Q36782751-439AEAC5-CFB2-41A5-8ABA-C838E0B0DF4A
P2860
Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Prediction of IDDM in the gene ...... tions of autoantibody markers.
@en
Prediction of IDDM in the gene ...... tions of autoantibody markers.
@nl
type
label
Prediction of IDDM in the gene ...... tions of autoantibody markers.
@en
Prediction of IDDM in the gene ...... tions of autoantibody markers.
@nl
prefLabel
Prediction of IDDM in the gene ...... tions of autoantibody markers.
@en
Prediction of IDDM in the gene ...... tions of autoantibody markers.
@nl
P2093
P356
P1433
P1476
Prediction of IDDM in the gene ...... tions of autoantibody markers.
@en
P2093
Bingley PJ
Bonifacio E
Bottazzo GF
Genovese S
Williams AJ
P304
P356
10.2337/DIAB.46.11.1701
P407
P577
1997-11-01T00:00:00Z